6,678 trials
Secondary Hyperparathyroidism Due to Renal Causes · Vitamin D Insufficiency · CKD Stage 3
Primary: Incidence and Severity of Treatment-Emergent Adverse Events (TEAE) as Assessed by Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. — 39; 12; 13; 10…
Type 2 Diabetes Mellitus
Primary: Gene Expression and Function Change of CD34+ Endothelial Progenitor Cells (Protein Expression) — 0.63; 0.33; 1.58; 0.90 ng/mL in serum
Obesity
Primary: Change in Body Weight (Percentage) — -6.61; -7.68 mean change in body weight (%)
Giant Cell Arteritis
Primary: Sustained Remission — 23 Participants
Tobacco Use Cessation
Primary: 7-day Point-prevalence Abstinence — 21.5; 15.8 Percentage of participants quit at 1-mo
Phrenic Nerve Paralysis
Primary: Diaphragm Excursion With Sigh — 4.2; 2.9 cm
Systolic Heart Failure
Primary: The Change in Platelet Aggregation Measured by the Accumetrics (VerifyNow P2Y12) Assay Between Baseline and Each Antiplatelet Medication — 66.4; 156.2 PRU (P2Y12…
Hypertension in Pregnancy · Preeclampsia Severe · Gestational Hypertension
Primary: Prolonged Hospitalization — 13; 17 Participants
Hand Dermatitis
Primary: Primary Outcome Measure for Efficacy (IGA) — 2.33; 2.20; 2.43; 2 score on a scale
E-Aminocaproic Acid · Bilateral Varus Rotational Osteotomy
Primary: Intraoperative Calculated Total Blood Loss — 535.7; 628.0 mL
Serious Mental Illness · Schizophrenia · Schizoaffective Disorder
Primary: Number of Participants on Adequate Cardiovascular Prevention Care (Defined as Taking a Statin and Angiotensin Medication) — 66; 8 Participants
Hepatitis C · Renal Insufficiency, Chronic · Disorder of Transplanted Kidney
Primary: SVR 12 — 19; 1; 1 Participants
PMDD · Stress · Mood
Primary: Acoustic Startle Response (ASR) Magnitude Based on Menstrual Cycle Phase — 54.2; 53.7; 56.4; 53.3 t score — p=0.139
MRI Sedation
Primary: Percentage of Participants at the DEX High Dose Versus Low Dose in the Combined Age Cohorts Who Did Not Require Concomitant PRO to Complete MRI — 63.2; 14.3 Percentage…
Anxiety Disorders,Generalized Anxiety Disorder
Primary: Change in Pediatric Anxiety Rating Scale (PARS) Severity Score — -6.38; -7.81 score on a scale — p=0.0281